Nutranomics, Inc. Logo

Nutranomics, Inc.

NNRX

(1.8)
Stock Price

0,00 USD

0% ROA

0% ROE

-0.55x PER

Market Cap.

1.532.470,00 USD

0% DER

0% Yield

0% NPM

Nutranomics, Inc. Stock Analysis

Nutranomics, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nutranomics, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (86.22%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0.01x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-61%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

5 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

7 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

8 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

9 ROA

The stock's ROA (-273.59%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

10 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

11 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

Nutranomics, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nutranomics, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Nutranomics, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nutranomics, Inc. Revenue
Year Revenue Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 2.402.769 100%
2015 1.789.325 -34.28%
2016 1.636.864 -9.31%
2019 59.544 -2649%
2020 871 -6736.28%
2021 1.756.918 99.95%
2022 2.846.786 38.28%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nutranomics, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 32.233 100%
2015 2.093 -1440.04%
2016 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nutranomics, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 14.250
2009 39.125 63.58%
2010 14.247 -174.62%
2011 14.839 3.99%
2012 23.567 37.03%
2014 2.475.687 99.05%
2015 1.646.375 -50.37%
2016 2.153.648 23.55%
2019 513.995 -319%
2020 409.375 -25.56%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nutranomics, Inc. EBITDA
Year EBITDA Growth
2008 -5.328
2009 -39.125 86.38%
2010 -14.247 -174.62%
2011 -14.839 3.99%
2012 -23.567 37.03%
2014 -1.909.997 98.77%
2015 -775.689 -146.23%
2016 -1.332.884 41.8%
2019 -573.610 -132.37%
2020 -595.510 3.68%
2021 -1.578.470 62.27%
2022 -8.351.190 81.1%
2023 0 0%
2024 0 0%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nutranomics, Inc. Gross Profit
Year Gross Profit Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 747.189 100%
2015 888.847 15.94%
2016 875.676 -1.5%
2019 21.565 -3960.64%
2020 -407 5398.53%
2021 -1.061.076 99.96%
2022 -3.075.922 65.5%
2023 0 0%
2024 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nutranomics, Inc. Net Profit
Year Net Profit Growth
2008 -23.172
2009 -39.125 40.77%
2010 -14.247 -174.62%
2011 -14.839 3.99%
2012 -23.567 37.03%
2014 -2.172.242 98.92%
2015 -1.217.479 -78.42%
2016 -3.495.208 65.17%
2019 -2.238.452 -56.14%
2020 -950.795 -135.43%
2021 -1.888.747 49.66%
2022 -6.629.775 71.51%
2023 0 0%
2024 0 0%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nutranomics, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nutranomics, Inc. Free Cashflow
Year Free Cashflow Growth
2008 -11.039
2009 -24.243 54.47%
2010 -5.644 -329.54%
2011 -9.127 38.16%
2012 -25.691 64.47%
2014 -634.821 95.95%
2015 -430.894 -47.33%
2016 -32.827 -1212.62%
2019 -167.847 80.44%
2020 -570.270 70.57%
2021 -2.350.927 75.74%
2022 -5.946.775 60.47%
2023 0 0%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nutranomics, Inc. Operating Cashflow
Year Operating Cashflow Growth
2008 -11.039
2009 -24.243 54.47%
2010 -5.644 -329.54%
2011 -9.127 38.16%
2012 -25.691 64.47%
2014 -633.360 95.94%
2015 -430.894 -46.99%
2016 -32.827 -1212.62%
2019 -167.847 80.44%
2020 -570.270 70.57%
2021 -1.922.485 70.34%
2022 -5.680.171 66.15%
2023 0 0%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nutranomics, Inc. Capital Expenditure
Year Capital Expenditure Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 1.461 100%
2015 0 0%
2016 0 0%
2019 0 0%
2020 0 0%
2021 428.442 100%
2022 266.604 -60.7%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nutranomics, Inc. Equity
Year Equity Growth
2008 22.953
2009 -6.572 449.25%
2010 -13.619 51.74%
2011 -28.458 52.14%
2012 17.975 258.32%
2014 -1.368.569 101.31%
2015 -1.455.688 5.98%
2016 -2.225.459 34.59%
2019 -6.360.103 65.01%
2020 -7.058.112 9.89%
2021 -2.794.829 -152.54%
2022 -10.552.391 73.51%
2023 0 0%
2024 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nutranomics, Inc. Assets
Year Assets Growth
2008 31.375
2009 7.482 -319.34%
2010 4.377 -70.94%
2011 4.305 -1.67%
2012 61.989 93.06%
2014 550.180 88.73%
2015 448.704 -22.62%
2016 408.363 -9.88%
2019 29.442 -1287.01%
2020 26.343 -11.76%
2021 16.546.713 99.84%
2022 18.034.739 8.25%
2023 0 0%
2024 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nutranomics, Inc. Liabilities
Year Liabilities Growth
2008 8.422
2009 14.054 40.07%
2010 17.996 21.9%
2011 32.763 45.07%
2012 44.014 25.56%
2014 1.918.749 97.71%
2015 1.904.392 -0.75%
2016 2.633.822 27.69%
2019 6.389.545 58.78%
2020 7.084.455 9.81%
2021 19.341.542 63.37%
2022 28.587.130 32.34%
2023 0 0%
2024 0 0%

Nutranomics, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-0.55x
Price To Sales Ratio
0.91x
POCF Ratio
-3.73
PFCF Ratio
-3.55
Price to Book Ratio
0
EV to Sales
0.91
EV Over EBITDA
-0.68
EV to Operating CashFlow
-3.47
EV to FreeCashFlow
-3.55
Earnings Yield
-1.8
FreeCashFlow Yield
-0.28
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.15
ROE
0.45
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-0.02
Capex to Revenue
0.01
Capex to Depreciation
0.04
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nutranomics, Inc. Dividends
Year Dividends Growth

Nutranomics, Inc. Profile

About Nutranomics, Inc.

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.

CEO
Mr. Jonathan Bishop
Employee
1
Address
11487 South 700 East
Salt Lake City, 84020

Nutranomics, Inc. Executives & BODs

Nutranomics, Inc. Executives & BODs
# Name Age
1 Mr. Geoffrey Bazegian
President & Chief Revenue Officer
70
2 Mr. Jonathan Bishop
Chief Executive Officer & Member of Advisory Board
70
3 Ms. Laura Riffel
Chief Operations Officer
70
4 Mr. Neil Zoller
Senior Vice President of Agricultural Supply Chain
70

Nutranomics, Inc. Competitors